Millipore, a life science company, and Novozymes Biopharma, a provider of industrial bio-solutions, have launched CellPrime rAlbumin AF-G, a completely animal-free cell culture supplement designed for large scale industrial bioprocessing applications.
CellPrime rAlbumin AF-G was developed in response to increasing demand for cell culture supplements that contain no human or animal ingredients in order to ease regulatory concerns for biopharmaceutical manufacturers. CellPrime rAlbumin AF-G offers multiple benefits including the maintenance of osmotic balance and transport, the distribution of fatty acids and amino acids, as well as improving consistency of customers’ industrial cell culture processes, the two companies said.
This new product will be manufactured by Novozymes Biopharma and sold exclusively through Millipore’s sales organization.
Andrew Bulpin, vice president of upstream bioprocessing business unit at Millipore, said: A critical part of Millipore’s long-term strategy is to expand our portfolio of animal-free cell culture supplements we can offer to our customers. CellPrime rAlbumin AF-G meets the unique challenges of industrial cell culture by providing a defined, animal-free albumin, which enables customers to take advantage of the benefits of albumin without the challenges associated with animal or human derived supplements.